Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hope for rapid equine influenza test
“Preventing a new influenza pandemic requires both vaccination and antiviral drugs to be administered within 48 hours of the infection."
Scientists say dipstick test could offer results in seconds 

A simple dipstick test could offer a rapid, non-invasive method of screening for equine influenza.

Iceni Diagnostics has a patent for its approach to detecting and distinguishing between human and avian flu. The company believes that with a slight modification, the test could be used for routine screening in horses before they travel to race meets and other gatherings.

Professor Robert Field, co-founder at Iceni, said 90 per cent of infections use carbohydrate recognition to bind with targets in humans and animals. This mechanism is specific to each strain of flu, so it can be used as a sensor for the disease.

“Our sensor uses sugars tagged with inexpensive gold nanoparticles,” he explained. “If the virus is present it will stick to the particles, pulling them closer together. This creates a photophysics reaction and the sample changes colour.

“We have found that there are differences between the carbohydrate detectors in the different types of flu. It is therefore possible to use a colour change to identify presence and absence of the virus and to distinguish between them.”

Using sugars instead of more commonly used protein-based diagnostics avoids the need for cold storage, meaning the test can be used worldwide with minimal training, and gives results in seconds.

According to Professor David Russell, chief scientist at Iceni, the new assay based on gold nanoparticles is much faster than current tests.

“Preventing a new influenza pandemic requires both vaccination and antiviral drugs to be administered within 48 hours of the infection in order to contain the disease,” he said.

“Current methods of detection require isolation and culturing of the virus, which may take several hours or even days to get the results. Using our test it would be possible to quickly identify infected animals at the stables and quarantine them, preventing the spread of disease.”

Iceni is now looking for investment to modify its sensor to produce a dip test for equine flu.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.